Gm19267 Pseudogene Detail

Summary

• Symbol
  Gm19267
• Name
  predicted gene, 19267

• Feature Type
  pseudogene
• IDs
  MGI:5011452
  NCBI Gene: 100502589
• Alliance
  gene page

Location &
Maps

• Sequence Map
  Chr15:82305652-82307648 bp, - strand

  From Ensembl annotation of GRCm39
  

• View this region in JBrowse
  

• Genome Browsers
  Ensembl | UCSC | NCBI

• Genetic Map
  Chromosome 15, 38.59 cM
• Mapping Data
  1 experiment

Strain
Comparison

• SNPs within 2kb
  97 from dbSNP Build 142
• Strain Annotations
  1

Strain	Gene Model ID	Feature Type	Coordinates
C57BL/6J	MGI_C57BL6J_5011452	pseudogene	Chr15:82305604-82307648 (-)
129S1/SvImJ	no annotation
A/J	no annotation
AKR/J	no annotation
BALB/cJ	no annotation
C3H/HeJ	no annotation
C57BL/6NJ	no annotation
CAROLI/EiJ	no annotation
CAST/EiJ	no annotation
CBA/J	no annotation
DBA/2J	no annotation
FVB/NJ	no annotation
LP/J	no annotation
NOD/ShiLtJ	no annotation
NZO/HlLtJ	no annotation
PWK/PhJ	no annotation
SPRET/EiJ	no annotation
WSB/EiJ	no annotation

Homology

• Gene Tree
  Gm19267
  

Mutations,
Alleles, and
Phenotypes

• Phenotype Summary
  20 phenotype references
  

• All Mutations and Alleles
  6
• Chemically induced (other)
  1
• Radiation induced
  1
• Targeted
  4
• Genomic Mutations
  6 involving Gm19267
• Find Mice (IMSR)
  0 strains or lines available

Expression

• Assay Results
  706

Tissue x Stage Matrix

• Other Mouse Links
  Expression Atlas

Sequences &
Gene Models

• All Sequences
  4

• Ensembl
  ENSMUSG00000116419 (Evidence)
• NCBI Gene
  100502589

Representative Sequences			Length	Strain/Species
genomic	ENSMUSG00000116419	Ensembl Gene Model | MGI Sequence Detail	1997	C57BL/6J
transcript	ENSMUST00000229517	Ensembl | MGI Sequence Detail	696	Not Applicable

References

• Summaries
  All 23

  Phenotypes 20
• Earliest
  J:7688 Lane PW, et al., Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered. 1984 Nov-Dec;75(6):435-9
• Latest
  J:286122 Henderson CJ, et al., An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials. Drug Metab Dispos. 2019 Jun;47(6):601-615